Skip to main content
Jamjoom Pharmaceuticals Factory Co. logo

Jamjoom Pharmaceuticals Factory Co. — Investor Relations & Filings

Ticker · 4015 ISIN · SA15QGU1UNH6 Saudi Exchange Manufacturing
Filings indexed 61 across all filing types
Latest filing 2026-04-23 Earnings Release
Country SA Saudi Arabia
Listing Saudi Exchange 4015

About Jamjoom Pharmaceuticals Factory Co.

http://https://www.jamjoompharma.com

Jamjoom Pharmaceuticals Factory Co. is a prominent pharmaceutical manufacturer specializing in the development, production, and distribution of a wide range of generic healthcare products. The company focuses on several key therapeutic areas, including ophthalmology, dermatology, cardiovascular health, and gastrointestinal medicine. It operates advanced manufacturing facilities that adhere to international quality standards, ensuring the delivery of effective and affordable medications. With a significant presence across the Middle East, North Africa, and Central Asia, the organization leverages its research and development capabilities to expand its product portfolio and address diverse medical needs. Its commitment to innovation and quality has established it as a leader in specialized segments, particularly in the ophthalmic market, where it provides a comprehensive suite of treatments.

Recent filings

Filing Released Lang Actions
Jamjoom Pharmaceuticals Factory Co. announces its Interim Financial results for the Period Ending on 2026-03-31 ( Three Months )
Earnings Release Classification · 1% confidence The document is an announcement of Jamjoom Pharmaceuticals’ interim (three-month) financial results with summary tables of revenue, profit, per-share metrics, commentary on year-over-year and quarter-over-quarter changes, and reference to an attached Earnings Release PDF. It is not the full interim report itself but rather the initial quarterly results announcement (key highlights only). This matches the definition of an Earnings Release (ER). Q1 2026
2026-04-23 English
Jamjoom Pharmaceuticals Factory Co. announces the board of director’s decision to distribute cash dividends for Second half of 2025 (Six months)
Regulatory Filings
2026-02-24 English
Jamjoom Pharmaceuticals Factory Co. announces its Annual Financial results for the period ending on 31-12-2025
Regulatory Filings
2026-02-24 English
Jamjoom Pharmaceuticals Factory Co. Announces providing a corporate guarantee to its Joint Venture in Algeria
Regulatory Filings
2026-01-18 English
Jamjoom Pharmaceuticals Factory Co. announces the Board of Directors' recommendation to transfer the entire balance of the statutory reserve to retained earnings
Regulatory Filings
2026-01-01 English
Jamjoom Pharmaceuticals Factory Co. announces the Signing of a Non-Binding Term Sheet with Pharmaceutical Investment Company, in relation to a potential strategic partnership
Regulatory Filings
2025-10-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.